Stock CYBN CYBIN INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cybin Inc.

Equities

CYBN

CA23256X1006

Market Closed - Nyse
Other stock markets
 01:30:00 29/06/2024 am IST 		5-day change 1st Jan Change
0.271 USD +2.46% Intraday chart for Cybin Inc. +2.65% -33.90%
26/06 Cybin Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
11/06 Cybin Inc. Appoints Atul R. Mahableshwarkar as Senior Vice President, Clinical Development CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYBIN INC. Stock Cybin Inc.
 21Cr - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
ARGENX SE Stock argenx SE
 2.6TCr -
BIONTECH SE Stock BioNTech SE
 1.94TCr -
GENMAB A/S Stock Genmab A/S
 1.59TCr
  1. Stock Market
  2. Equities
  3. CYBN Stock
  4. Charts Cybin Inc.
  5. Sector Chart